Pharma Commercial Mock
IQVIA™
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-10-30·Marten Veskimae
Brand-level trends · ZENVARA™

Weekly NPA dashboard · west

TRx (week)
490▼ 8.4%
vs WK29, 2026-10-30
NRx (week)
140▼ 16.7%
vs prior week
NBRx (week)
29▼ 17.1%
new-to-brand
Cumulative TRx
2,122
4-week window
📈TRx — plan vs actual
024849574310-0910-1610-2310-30
Plan Actual
📊NRx ⨉ NBRx trend
10-0910-1610-2310-30
NRx NBRx
🍩Channel mix
RETAIL34%MAIL58%LTC8%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 4 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-10-0956917439674-15.6%569
2026-10-1652816337674-21.7%1,097
2026-10-2353516835675-20.7%1,632
2026-10-3049014029675-27.4%2,122
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.